Services

Premanand Adaikalasamy is a seasoned expert in biotechnology and bioinformatics, with extensive experience in genomics, computational biology, and data analysis. His leadership and scientific acumen form the backbone of Vettri BioMed, driving research excellence and technological innovation. As the CEO, Dr. Premanand envisions a future where bioinformatics bridges the gap between data and discovery, transforming healthcare and life sciences.

Genomics and NGS Analysis

At Vettri BioMed Technologies, we leverage cutting-edge Next-Generation Sequencing (NGS) technologies to decode the complexities of the genome, transcriptome, and metagenome. Our genomics and NGS services offer high-throughput, cost-effective, and precise solutions for comprehensive genetic analysis, driving discoveries in clinical research, biotechnology, and personalized medicine.

From whole-genome sequencing to targeted panels, our services empower researchers with unparalleled insights into genetic variations, disease mechanisms, and microbial communities. We provide end-to-end sequencing and bioinformatics solutions, ensuring accurate interpretation and actionable results.

Our Key Genomics and NGS Services

1. Genome Sequencing
Unlock the full potential of genetic analysis through comprehensive genome sequencing solutions that map the entire genetic landscape.

Whole Genome Sequencing (WGS):
Delivers an in-depth view of the entire genome, identifying rare variants, large structural changes, and novel mutations critical for understanding genetic diseases, oncology, and evolutionary biology.
Whole Exome Sequencing (WES):
Focuses on protein-coding regions (exons) that represent about 1% of the genome but contain 85% of known disease-causing mutations. WES is an efficient, cost-effective approach for clinical diagnostics and rare disease research.

2. Metagenome Analysis
Explore microbial diversity and function within complex environments by sequencing entire microbial communities directly from samples.

16S rRNA Sequencing (Bacteria & Archaea):
Ideal for profiling bacterial populations, understanding microbiomes, and detecting pathogenic shifts.
18S rRNA Sequencing (Eukaryotes):
Enables the study of microbial eukaryotes, providing insights into fungal and parasitic populations.
ITS (Internal Transcribed Spacer) Sequencing:
Targets fungal communities, offering precise identification of species diversity and composition in various environments.

3. Transcriptome Analysis
Capture the dynamic nature of gene expression with transcriptome sequencing, revealing functional insights at the RNA level.

Total RNA Sequencing:
Provides a holistic view of all RNA molecules, covering coding and non-coding regions.
mRNA Sequencing:
Focuses on messenger RNA, shedding light on gene expression and regulation.
Small RNA and miRNA Sequencing:
Profiles small regulatory RNAs involved in gene silencing and post-transcriptional regulation.
Single-Cell RNA Sequencing:
Analyzes gene expression at the single-cell level, unraveling cellular heterogeneity and unique cell populations.

4. Targeted Panel Sequencing
Gain precise insights into specific genetic mutations associated with diseases by sequencing curated gene panels.

Lung Gene Panel (126 genes):
Comprehensive analysis of genes linked to lung cancers, aiding in diagnosis and therapeutic decisions.
Solid Tumor Gene Panel (126 genes):
Targets key mutations in solid tumors, offering insights into various cancers for precision oncology.
Sarcoma Gene Panel (113 genes):
Specialized for identifying genetic alterations in sarcoma and soft tissue tumors.
Myeloid Gene Panel (98 genes):
Focused on mutations linked to myeloid malignancies, including leukemias and lymphomas.
Comprehensive ctDNA Panel (126 genes):
Liquid biopsy solution for non-invasive cancer monitoring and minimal residual disease detection.
Endometrium Panel (26 genes):
Targets genetic changes associated with endometrial cancers.
Colon Panel (24 genes):
Profiles mutations driving colorectal cancer, aiding in early detection and prognosis.
Hereditary Gene Panel (74 genes):
Screens for inherited cancer predispositions, providing risk assessment for hereditary syndromes.
HGP-Breast Cancer Panel (26 genes):
Identifies breast cancer-specific genetic alterations for targeted therapy.
HGP-Gastrointestinal Panel (24 genes):
Analyzes genes linked to gastrointestinal malignancies, enhancing diagnostic accuracy.
Comprehensive Genomic Profiling (519 genes):
An all-inclusive panel for extensive tumor profiling, supporting advanced cancer research and personalized treatment plans.